Where is the live CopyMark page for USPTO serial 76380523?

The live record is at https://getcopymark.com/trademark/76380523. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns MULTI-DIMENSIONAL LIPID MODIFIER?

According to the public USPTO record for serial number 76380523, the listed owner(s) include: Kos Pharmaceuticals, Inc., Kos Pharmaceuticals, Inc., KOS LIFE SCIENCES, INC..

What is USPTO serial number 76380523?

Serial number 76380523 is the USPTO application identifier for the mark MULTI-DIMENSIONAL LIPID MODIFIER. It is used to track examination, publication, and registration of this trademark.

What is the current status of MULTI-DIMENSIONAL LIPID MODIFIER?

MULTI-DIMENSIONAL LIPID MODIFIER (76380523) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover MULTI-DIMENSIONAL LIPID MODIFIER?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: MULTI-DIMENSIONAL LIPID MODIFIER Serial# 76380523 | status 601; last event ACEC | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MULTI-DIMENSIONAL LIPID MODIFIER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen P. Bechtold

KAREN P BECHTOLD KOS PHARMACEUTICALS INCONE CEDAR BROOK DRCRANBURY, NJ 08512UNITED STATES

Goods and services

Class	Description	Status	First use
005	pharmaceutical preparation for the treatment of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, and respiratory and infectious diseases	ACTIVE	Jan 23, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Dec 13, 2005	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Nov 14, 2005	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Nov 14, 2005	MAIL	PAPER RECEIVED	—
Feb 14, 2005	MAB1	ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT	—
Feb 14, 2005	ABN1	ABANDONMENT - EXPRESS MAILED	—
Feb 11, 2005	EXAR	TEAS EXPRESS ABANDONMENT RECEIVED	—
Aug 13, 2004	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2004	DOCK	ASSIGNED TO EXAMINER	—
Aug 3, 2004	SUPC	STATEMENT OF USE PROCESSING COMPLETE	—
Aug 3, 2004	EX3G	SOU EXTENSION 3 GRANTED	—
Jul 15, 2004	CFIT	CASE FILE IN TICRS	—
Jul 10, 2004	IUAF	USE AMENDMENT FILED	—
Jul 10, 2004	EISU	TEAS STATEMENT OF USE RECEIVED	The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 7, 2004	EXT3	SOU EXTENSION 3 FILED	—
Jul 7, 2004	EEXT	SOU TEAS EXTENSION RECEIVED	The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 29, 2004	EX2G	SOU EXTENSION 2 GRANTED	—
Jan 6, 2004	EXT2	SOU EXTENSION 2 FILED	—
Jan 6, 2004	EEXT	SOU TEAS EXTENSION RECEIVED	The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 7, 2003	EEXT	SOU TEAS EXTENSION RECEIVED	The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 3, 2003	EX1G	SOU EXTENSION 1 GRANTED	—
Jul 3, 2003	EXT1	SOU EXTENSION 1 FILED	—
Jan 7, 2003	NOAM	NOA MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 15, 2002	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2002	NPUB	NOTICE OF PUBLICATION	—
Jul 17, 2002	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Jul 9, 2002	CNEA	EXAMINER'S AMENDMENT MAILED	—
Jul 2, 2002	DOCK	ASSIGNED TO EXAMINER	—

MULTI-DIMENSIONAL LIPID MODIFIER